Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus
OBJECTIVES: The systemic and cognitive side effects of hepatitis C virus (HCV) therapy may be incapacitating, necessitating dose reductions or abandonment of therapy. Oral cannabinoid-containing medications (OCs) ameliorate chemotherapy-induced nausea and vomiting, as well as AIDS wasting syndrome....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2008/725702 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564073301016576 |
|---|---|
| author | Cecilia T Costiniuk Edward Mills Curtis L Cooper |
| author_facet | Cecilia T Costiniuk Edward Mills Curtis L Cooper |
| author_sort | Cecilia T Costiniuk |
| collection | DOAJ |
| description | OBJECTIVES: The systemic and cognitive side effects of hepatitis C virus (HCV) therapy may be incapacitating, necessitating dose reductions or abandonment of therapy. Oral cannabinoid-containing medications (OCs) ameliorate chemotherapy-induced nausea and vomiting, as well as AIDS wasting syndrome. The efficacy of OCs in managing HCV treatment-related side effects is unknown. |
| format | Article |
| id | doaj-art-a0f05dd98ee141349023b9e433622b29 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-a0f05dd98ee141349023b9e433622b292025-02-03T01:11:53ZengWileyCanadian Journal of Gastroenterology0835-79002008-01-0122437638010.1155/2008/725702Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C VirusCecilia T Costiniuk0Edward Mills1Curtis L Cooper2Department of Internal Medicine, University of Ottawa, Ottawa, Ontario, CanadaBritish Columbia Centre of Excellence in HIV/AIDS, University of British Columbia, Vancouver, British Columbia, CanadaUniversity of Ottawa, Division of Infectious Diseases, The Ottawa Hospital — General Campus, Ottawa Health Research Institute, Ottawa, Ontario, CanadaOBJECTIVES: The systemic and cognitive side effects of hepatitis C virus (HCV) therapy may be incapacitating, necessitating dose reductions or abandonment of therapy. Oral cannabinoid-containing medications (OCs) ameliorate chemotherapy-induced nausea and vomiting, as well as AIDS wasting syndrome. The efficacy of OCs in managing HCV treatment-related side effects is unknown.http://dx.doi.org/10.1155/2008/725702 |
| spellingShingle | Cecilia T Costiniuk Edward Mills Curtis L Cooper Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus Canadian Journal of Gastroenterology |
| title | Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus |
| title_full | Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus |
| title_fullStr | Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus |
| title_full_unstemmed | Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus |
| title_short | Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus |
| title_sort | evaluation of oral cannabinoid containing medications for the management of interferon and ribavirin induced anorexia nausea and weight loss in patients treated for chronic hepatitis c virus |
| url | http://dx.doi.org/10.1155/2008/725702 |
| work_keys_str_mv | AT ceciliatcostiniuk evaluationoforalcannabinoidcontainingmedicationsforthemanagementofinterferonandribavirininducedanorexianauseaandweightlossinpatientstreatedforchronichepatitiscvirus AT edwardmills evaluationoforalcannabinoidcontainingmedicationsforthemanagementofinterferonandribavirininducedanorexianauseaandweightlossinpatientstreatedforchronichepatitiscvirus AT curtislcooper evaluationoforalcannabinoidcontainingmedicationsforthemanagementofinterferonandribavirininducedanorexianauseaandweightlossinpatientstreatedforchronichepatitiscvirus |